Detalhe da pesquisa
1.
Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective study.
Am J Hematol
; 98(2): 300-308, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588409
2.
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.
Cancer
; 126(2): 293-303, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31568564
3.
Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer.
J Clin Oncol
; 41(22): 3851-3862, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36977289
4.
Pembrolizumab as monotherapy in locally advanced cutaneous squamous cell carcinoma.
Expert Rev Anticancer Ther
; 22(10): 1029-1038, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36106496
5.
Prognostic significance of human papillomavirus status and treatment modality in hypopharyngeal cancer.
Head Neck
; 43(10): 3042-3052, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34165223
6.
Pembrolizumab-induced Hemophagocytic Lymphohistiocytosis: an immunotherapeutic challenge.
Cancers Head Neck
; 5: 3, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32025343
7.
Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics.
Blood Adv
; 4(2): 253-262, 2020 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31945157
8.
Clinical Trials Investigating Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer.
Rev Recent Clin Trials
; 11(4): 297-305, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27457350
9.
New Oral Anticoagulants and Their Reversal.
Curr Drug Saf
; 10(3): 208-16, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25877809
10.
Small-molecule inhibitors of Bcl-2 family proteins as therapeutic agents in cancer.
Recent Pat Anticancer Drug Discov
; 3(1): 20-30, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18289121